Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 27, 2015

View Archived Issues

Novel inhibitors of InhA show promising results for the treatment of MDR-TB

Ipsen reports topline phase III data on Dysport in lower limb spasticity

FDA approves Natpara for treatment of hypocalcemia in patients with hypoparathyroidism

EMA CHMP recommends approval of lamivudine/raltegravir for HIV-1 infection

Torii files Japanese NDA for sublingual immunotherapy for dust mite allergy

Five Prime Therapeutics reviews product development

CDK inhibitors disclosed by Bayer

Japan Tobacco divulges novel PDHK inhibitors

Dosing begins in phase I/II trial of SBC-103 in mucopolysaccharidosis IIIB

FDA approves Triferic for iron replacement and hemoglobin maintenance in CKD

BMS patents novel indoleamine 2,3-dioxygenase 1 inhibitors

Insys Therapeutics receives U.S. orphan drug designation for liposomal encapsulated paclitaxel

Researchers from Genentech and Roche disclose new BTK inhibitors

Sichuan Haisco presents novel FFAR1 agonists for diabetes

Gem Pharmaceuticals enrolls patients in phase II GPX-150 trial in sarcoma

Lion Biotechnologies amends CRADA with NCI to include new cancer indications

New cytidine analogue inhibits gemcitabine-resistant tumor cell growth

Phase I data for ABT-700 in GEC patients

BIRD Foundation grant supports Orgenesis and Pall's efforts in diabetes

EMA grants orphan drug designation to ApoCell for GVHD

Takeda launches fomepizole in Japan for ethylene glycol and methanol poisoning

Opsona Therapeutics initiates phase I/II trial of OPN-305 in myelodysplastic syndrome

FDA grants fast track designation to BCX-4161 for hereditary angioedema

FDA grants orphan drug status to Antroquinonol for pancreatic cancer

EMA adopts positive opinion on Ikervis eye drops

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...